Acetylated c-Myc exhibits increased stability and transcriptional activity, upregulating key glycolytic genes such as GLUT1, HK2, and PFKFB3. This TACC3-driven metabolic reprogramming facilitates abnormal glycolysis, supporting bladder cancer growth (Fig. 6N). The gene discussed is SLC2A1; the disease is urinary bladder carcinoma.